Abiopharma

News list

GeneDx Holdings (WGSWW)

SEC News
Oct. 28, 2025, 10:43 UTC

(19% Negative) GeneDx Holdings Corp. (WGSWW) Reports Q4 2025 Financial Results

Full text

News bot Oct. 28, 2025, 10:44 a.m.

📋 GeneDx Holdings Corp. (WGSWW) - Financial Results

Filing Date: 2025-10-28

Accepted: 2025-10-28 06:43:04

Event Type: Financial Results

Event Details:

GeneDx Holdings (WGSWW) Reports Q4 2025 Financial Results GeneDx Holdings (WGSWW) announced its financial results for the period ending Q4 2025. Key Financial Highlights:

Revenue: 598
Net Income: $14
EPS: (0.31)
Cash and equivalents: 96958
- Reported third quarter 2025 revenues of $
- 7 million with 65% year
- year growth in exome and genome test revenue

📊 Key Financial Metrics (Year-over-Year Comparison):

Metric	2025	2024	Change ($)	Change (%)
Revenue	114.70K	2.05K	$112.65K	+5505.91%
Prepaid Expenses Other Current Assets	11.00K	8.50K	$2.49K	+29.32%
Operating Lease Right Of Use Assets	24.20K	25.61K	$-1.41K	-5.52%
Property Equipment Net	42.42K	32.89K	$9.53K	+28.97%
Intangible Assets Net	172.59K	158.60K	$13.98K	+8.82%
Other Assets	4.31K	4.31K	$8.00	+0.19%
Nonoperating Expenses Income Net Interest Expense	-843.00	-2.02K	$1.18K	+58.25%
Nonoperating Expenses Income Net Net Loss	-8.31K	-8.31K	$0.00	+0.00%
Operating Activities Net Loss	-3.35K	-3.35K	$0.00	+0.00%
Revenue	114.70K	2.05K	$112.65K	+5505.91%
Net Loss	-7.63K	-7.63K	$0.00	+0.00%
Prepaid Expenses and Other Current Assets	11.00K	8.50K	$2.49K	+29.32%
Property and Equipment, Net	42.42K	32.89K	$9.53K	+28.97%
Intangible Assets, Net	172.59K	158.60K	$13.98K	+8.82%
Other Assets	4.31K	4.31K	$8.00	+0.19%
Accounts Payable	50.33K	50.33K	$0.00	+0.00%
Interest Expense	-562.00	-843.00	$281.00	+33.33%

💼 Business Developments:

Partnership
Acquisition
Licensing: Not available
Regulatory Approval: Not available
Executive Changes: Not available

Structured Data:

Company Name: GeneDx Holdings
CIK: 0001818331
Ticker Symbol: WGSWW
Period End Date: 2025-10-28
Document Type: 8-K